基于温阳补气摄血理论探讨参附注射液防治出血性疾病的研究进展

摘要/Abstract

摘要： 在现代医学临床中,出血性疾病的发生多集中在心、脑、肺、胃肠等器官,其诊疗在保守治疗阶段以出血后的止血凝血和防治性的抗凝抗栓为主,都是基于单一脏器的对症性治疗,而传统中医药针对出血性疾病的诊疗概念则更加强调整体和多样性,其治疗不单纯于止血,更多是从无形之气到有形之血,而补气调摄之法则是主要的治疗准则。本文基于参附注射液的温阳补气之性和此药在临床广泛便捷的运用,综述参附注射液在出血性疾病方面的诊疗进展,以期在未来中西医结合的诊疗中,更多地将中医药的气血同治、双向调节的治疗理念运用至临床。

关键词: 参附注射液, 凝血因子, 抗血栓, 温阳补气法, 综述

Abstract: In modern medicine, the occurrence of hemorrhagic diseases is mostly concentrated in the heart, brain, lung, gastrointestinal organs, etc. The treatment of these diseases is mainly based on hemostasis and coagulation after bleeding and anticoagulation and antithrombosis, which are all symptomatic treatments based on a single organ. Based on the warming properties of Shenfu injection and the widespread and convenient use of this medicine in clinical practice, the therapeutic progress of Shenfu injection in the treatment of bleeding disorders is reviewed, with a view to applying the therapeutic concepts of Qi and Blood together and two-way regulation in Chinese and Western medicine in the future.

Key words: Shenfu injection, coagulation factor, anti-thrombotic, warming the Yang and tonifying the Qi, review

中图分类号:

高远. 基于温阳补气摄血理论探讨参附注射液防治出血性疾病的研究进展[J]. 中华养生保健, 2023, 41(4): 62-65.

GAO Yuan. Research Progress in the Prevention and Treatment of Bleeding Disorders with Shenfu Injection Based on the Theory of Warming Yang and Tonifying Qi and Regulating Blood[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(4): 62-65.

参考文献

[1] 尚鹏鑫,贺千里,杨仕年.温阳益气法在危急重症治疗中的应用[J].中医杂志,2017,58(12):1013-1016.
[2] 张运希,王伟伟,王敏.加用参附注射液治疗十二指肠溃疡合并出血疗效观察[J].贵阳中医学院学报,2005(1):29-30.
[3] 宋欣伟,骆永忠.大剂量参附注射液辅助治疗肝硬化食管曲张静脉破裂出血的临床观察[J].中国中西医结合杂志,2002(3):211-212.
[4] ZHANG M Q, ZHANG Q, YUAN W, et al.Protective Effect of Shenfu Injection on Vascular Endothelial Damage in a Porcine Model of Hemorrhagic Shock[J]. Chin J Integr Med,2022,28(9):794-801.
[5] WU J, LI Z, YUAN W, et al.Shenfu injection improves cerebral microcirculation and reduces brain injury in a porcine model of hemorrhagic shock[J]. Clin Hemorheol Microcirc,2021,78(2):175-185.
[6] LIU W B, HAN X H, GUO Y Y, et al.Effects of tumor necrosis factor and E-selectin on coronary artery flow[J]. Eur Rev Med Pharmacol Sci, 2017,21(8):1843-1849.
[7] WU J, LI C, YUAN W.Effects of Shenfu injection on macrocirculation and microcirculation during cardiopulmonary resuscitation[J]. J Ethnopharmacol,2016,180:97-103.
[8] ZHU J, KANG L, YE Q, et al.Effects of Shenfu injection and its main components on the contraction of isolated rat thoracic aortic rings[J]. PLoS One,2013,8(10):e78026.
[9] 张建峰,汤小斌,汪群智.参附注射液联合盐酸纳美芬对老年创伤性休克患者内皮功能、炎性指标和血流动力学的影响[J].中国老年学杂志,2019,39(23):5766-5769.
[10] 程济玲. 参附注射液联合甘露醇、HSH40对急性颅内高压合并失血性休克患者脑氧代谢、脑血流动力学、炎性反应及预后的影响[J].现代中西医结合杂志,2019,28(22):2416-2420,2424.
[11] 陈建望,徐蓉,谢秀莲,等.参附注射液对外伤性蛛网膜下腔出血患者脑血流动力学的影响[J].中国中医药科技,2013,20(2):181-182.
[12] 贺建辉,郭慧梅,李炜,等.参附注射液对外伤性蛛网膜下腔出血患者脑脊液一氧化氮、内皮素-1的影响[J].现代中西医结合杂志,2017, 26(10):1083-1085.
[13] 曾建华,陈丹慧,王碧,等.参附注射液对老年急性失血再灌注大鼠脑水通道蛋白-4的影响[J].中国老年学杂志,2018,38(11):2731-2732.
[14] 刘亮,徐志明,胡有志,等.冠状动脉内注射参附注射液对急性冠脉综合征术中慢血流-无复流的影响[J].中西医结合心脑血管病杂志,2019,17(23):3759-3761.
[15] 马民,曹斌,常秀云,等.参附注射液调节创伤性急性肺损伤肺血管内皮细胞功能的临床研究[J].系统医学,2019,4(10):36-38.
[16] YIN Q, LIU B, WU C, et al.Effects of Shen-Fu injection on coagulation-fibrinolysis disorders in a porcine model of cardiac arrest[J].Am J Emerg Med,2016,34(3):469-476.
[17] 张宏宇. 参附注射液在急诊多发伤伴发休克治疗中的应用效果及对相关血液指标的影响[J].中国医学创新,2022,19(13):131-136.
[18] 徐冰,赵剡,夏剑.参附注射液对创伤失血性休克患者凝血功能和炎性因子的影响[J].海南医学院学报,2015,21(2):206-208,211.
[19] 胡彬,王义兵,吴利东.参附注射液对多发伤合并休克患者凝血功能及C-反应蛋白的影响[J].中国急救医学,2021,41(2):127-131.
[20] 张浩,胡佩佩,王智兰,等.参附注射液对于脓毒症肺损伤机械通气患者炎症因子水平及凝血功能的影响[J].中外医疗,2022,41(6):17-21.
[21] 王明华. 参附注射液联合低分子肝素对小儿脓毒血症血浆NT-ProBNP、Cys、凝血功能和预后的影响[J].新疆医学,2019,49(3):252-254.
[22] 李振良. 参附注射液联合小剂量糖皮质激素治疗对老年重症肺炎患者内皮功能与凝血状态的影响[J].现代中西医结合杂志,2019, 28(15):1668-1671.
[23] 夏雷风,谢宗贤.早期应用参附注射液联合注射用炎琥宁治疗老年重症社区获得性肺炎疗效观察及对血清炎症指标与凝血状态的影响[J].河北中医,2017,39(12):1801-1805,1811.
[24] 沈佳,陈彬,郑关荣.尼莫地平注射液联合参附注射液治疗创伤性蛛网膜下腔出血的临床研究[J].中国临床药理学杂志,2017,33(19): 1865-1867.
[25] 陈建望,徐蓉,谢秀莲,等.参附注射液治疗外伤性蛛网膜下腔出血后凝血相关因子的变化及其临床意义[J].浙江创伤外科,2013, 18(3):308-310.
[26] 童玖兴. 参附注射液对脑梗塞患者凝血及神经功能的影响临床观察[J].北方药学,2016,13(7):84-85.
[27] 焦保庭,檀晓东,张邵东.参附注射液对腹部手术患者术后深静脉血栓发生及凝血功能的影响[J].中国处方药,2020,18(8):138-140.
[28] 朱军华,肖志英,李智英.参附注射液对腹部大手术后下肢深静脉血栓形成的预防治疗作用[J].中国中医急症,2016,25(9):1826-1827.
[29] 戚振红,邱华耀,陈家鑫,等.不同剂量参附注射液对髋关节置换术后下肢深静脉栓塞的治疗评价[J].中国中医急症,2016,25(1):169-171.
[30] 郑俊飞,陈志勇,朱姝,等.参附注射液对骨科创伤手术患者血清CRP、Fib和D-D水平的影响[J].江苏医药,2018,44(8):936-938.
[31] 雷李美,蓝翔,考验,等.参附注射液对严重创伤患者T细胞亚群、天然杀伤细胞及预后的影响[J].中华全科医学,2016,14(5):743-745.
[32] 钱来军,王珏,王永明.骨髓腔输注参附注射液对多发性骨折失血患者的影响[J].中国药物与临床,2020,20(15):2617-2618.
[33] 陈戈,林永春.参附注射液对脑微出血诱发认知功能障碍的缓解作用[J].中国医院用药评价与分析,2019,19(11):1347-1349.
[34] 尹璋星,赵文旭.参附注射液、甲强龙联合亚低温治疗动脉瘤性蛛网膜下腔出血并发神经源性肺水肿疗效观察[J].现代中西医结合杂志,2019,28(7):710-713,743.
[35] 夏森林,徐杰丰,沈鹏,等.参附注射液对猪创伤性心脏骤停复苏后肾损伤的保护作用研究[J].中国中西医结合杂志,2020,40(1):70-74.
[36] 陆宗庆. 参附注射液对于重度失血性休克后大鼠急性肠道损伤的保护作用及其机制研究[D].合肥:安徽医科大学,2022.